Evolution May Have Deleted Neanderthal DNA

Natural selection may be behind the dearth of Neanderthal DNA in modern humans.

Written byJoshua A. Krisch
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA COMMONS, DRMIKEBAXTERThe modern human genome should, by all accounts, have more Neanderthal genes. Experts agree that early European and Asian humans almost certainly bred with Neanderthals, an ideal recipe for rich, complex genotypes 60,000 years later. And yet, non-African humans tend to have less than 4 percent Neanderthal DNA. Researchers may now have figured out why: in a November 8 PLOS Genetics study, scientists pinpoint natural selection, and the relatively large populations of humans versus Neanderthals, as reasons for these apparent reductions in Neanderthal DNA.

“The human population size has historically been much larger, and this is important since selection is more efficient at removing deleterious variants in large populations,” study coauthor Ivan Juric, population geneticist at 23andMe, said in a statement. “Therefore, a weakly deleterious variant that could persist in Neanderthals could not persist in humans.”

Juric and colleagues developed a method for quantifying the average strength of natural selection against Neanderthal genes. They found that selection against individual Neanderthal alleles is very weak, suggesting that our ancient ancestors accumulated many slightly deleterious alleles, which—within their small enclaves—were hardly noticeable when inherited. But once Neanderthals integrated into larger human populations, the researchers proposed, these alleles entered the crucible of natural selection and were weeded out of modern human genomes.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies